155 related articles for article (PubMed ID: 34609076)
1. Lymphovascular invasion quantification could improve risk prediction of lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma.
van de Ven SEM; Suzuki L; Gotink AW; Ten Kate FJC; Nieboer D; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Curvers W; van Lijnschoten IG; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
United European Gastroenterol J; 2021 Nov; 9(9):1066-1073. PubMed ID: 34609076
[TBL] [Abstract][Full Text] [Related]
2. Individual risk calculator to predict lymph node metastases in patients with submucosal (T1b) esophageal adenocarcinoma: a multicenter cohort study.
Gotink AW; van de Ven SEM; Ten Kate FJC; Nieboer D; Suzuki L; Weusten BLAM; Brosens LAA; van Hillegersberg R; Alvarez Herrero L; Seldenrijk CA; Alkhalaf A; Moll FCP; Schoon EJ; van Lijnschoten I; Tang TJ; van der Valk H; Nagengast WB; Kats-Ugurlu G; Plukker JTM; Houben MHMG; van der Laan JS; Pouw RE; Bergman JJGHM; Meijer SL; van Berge Henegouwen MI; Wijnhoven BPL; de Jonge PJF; Doukas M; Bruno MJ; Biermann K; Koch AD
Endoscopy; 2022 Feb; 54(2):109-117. PubMed ID: 33626582
[TBL] [Abstract][Full Text] [Related]
3. Can the Risk of Lymph Node Metastases Be Gauged in Endoscopically Resected Submucosal Esophageal Adenocarcinomas? A Multi-Center Study.
Boys JA; Worrell SG; Chandrasoma P; Vallone JG; Maru DM; Zhang L; Blackmon SH; Dickinson KJ; Dunst CM; Hofstetter WL; Lada MJ; Louie BE; Molena D; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):6-12; discussion 12. PubMed ID: 26408330
[TBL] [Abstract][Full Text] [Related]
4. The prevalence of lymph node metastases in patients with T1 esophageal adenocarcinoma a retrospective review of esophagectomy specimens.
Leers JM; DeMeester SR; Oezcelik A; Klipfel N; Ayazi S; Abate E; Zehetner J; Lipham JC; Chan L; Hagen JA; DeMeester TR
Ann Surg; 2011 Feb; 253(2):271-8. PubMed ID: 21119508
[TBL] [Abstract][Full Text] [Related]
5. Management of patients with T1b esophageal adenocarcinoma: a retrospective cohort study on patient management and risk of metastatic disease.
Schölvinck D; Künzli H; Meijer S; Seldenrijk K; van Berge Henegouwen M; Bergman J; Weusten B
Surg Endosc; 2016 Sep; 30(9):4102-13. PubMed ID: 27357927
[TBL] [Abstract][Full Text] [Related]
6. Lymphovascular invasion as a tool to further subclassify T1b esophageal adenocarcinoma.
Cen P; Hofstetter WL; Correa AM; Wu TT; Lee JH; Ross WA; Davilla M; Swisher SG; Fukami N; Rashid A; Maru D; Ajani JA
Cancer; 2008 Mar; 112(5):1020-7. PubMed ID: 18205187
[TBL] [Abstract][Full Text] [Related]
7. Endoscopic and surgical resection of T1a/T1b esophageal neoplasms: a systematic review.
Sgourakis G; Gockel I; Lang H
World J Gastroenterol; 2013 Mar; 19(9):1424-37. PubMed ID: 23539431
[TBL] [Abstract][Full Text] [Related]
8. Multifocal neoplasia and nodal metastases in T1 esophageal carcinoma: implications for endoscopic treatment.
Altorki NK; Lee PC; Liss Y; Meherally D; Korst RJ; Christos P; Mazumdar M; Port JL
Ann Surg; 2008 Mar; 247(3):434-9. PubMed ID: 18376186
[TBL] [Abstract][Full Text] [Related]
9. Lymphovascular invasion of tumor cells in lymph node metastases has a negative impact on survival in esophageal cancer.
Schiefer AI; Schoppmann SF; Birner P
Surgery; 2016 Aug; 160(2):331-40. PubMed ID: 27085684
[TBL] [Abstract][Full Text] [Related]
10. Surgical Management of Early-Stage Esophageal Adenocarcinoma Based on Lymph Node Metastasis Risk.
Newton AD; Predina JD; Xia L; Roses RE; Karakousis GC; Dempsey DT; Williams NN; Kucharczuk JC; Singhal S
Ann Surg Oncol; 2018 Jan; 25(1):318-325. PubMed ID: 29147928
[TBL] [Abstract][Full Text] [Related]
11. Use of Immunostaining for the diagnosis of Lymphovascular invasion in superficial Barrett's esophageal adenocarcinoma.
Hosono I; Miyahara R; Furukawa K; Funasaka K; Sawada T; Maeda K; Yamamura T; Ishikawa T; Ohno E; Nakamura M; Kawashima H; Yokoi T; Tsukamoto T; Hirooka Y; Fujishiro M
BMC Gastroenterol; 2020 Jun; 20(1):175. PubMed ID: 32503448
[TBL] [Abstract][Full Text] [Related]
12. The management and long-term outcomes of endoscopic and surgical treatment of early esophageal adenocarcinoma.
Saunders JH; Al-Zubaidi S; Waller RC; Ortiz-Fernandez-Sordo J; Parsons SL; Ragunath K; Kaye PV;
Dis Esophagus; 2020 Sep; 33(9):. PubMed ID: 32090253
[TBL] [Abstract][Full Text] [Related]
13. Esophageal submucosa: the watershed for esophageal cancer.
Raja S; Rice TW; Goldblum JR; Rybicki LA; Murthy SC; Mason DP; Blackstone EH
J Thorac Cardiovasc Surg; 2011 Dec; 142(6):1403-11.e1. PubMed ID: 22093714
[TBL] [Abstract][Full Text] [Related]
14. Inter-Observer Variability in the Interpretation of Endoscopic Mucosal Resection Specimens of Esophageal Adenocarcinoma: Interpretation of ER specimens.
Worrell SG; Boys JA; Chandrasoma P; Vallone JG; Dunst CM; Johnson CS; Lada MJ; Louie BE; Watson TJ; DeMeester SR
J Gastrointest Surg; 2016 Jan; 20(1):140-4; discussion 144-5. PubMed ID: 26503261
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of lymphovascular invasion in lymph node-negative superficial esophageal squamous cell carcinoma.
Oguma J; Ozawa S; Kazuno A; Yamamoto M; Ninomiya Y; Yatabe K; Makuuchi H; Ogura G
Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30883635
[TBL] [Abstract][Full Text] [Related]
16. Duplicated muscularis mucosae invasion has similar risk of lymph node metastasis and recurrence-free survival as intramucosal esophageal adenocarcinoma.
Estrella JS; Hofstetter WL; Correa AM; Swisher SG; Ajani JA; Lee JH; Bhutani MS; Abraham SC; Rashid A; Maru DM
Am J Surg Pathol; 2011 Jul; 35(7):1045-53. PubMed ID: 21602659
[TBL] [Abstract][Full Text] [Related]
17. Endoscopic resection of Barrett's adenocarcinoma: Intramucosal and low-risk tumours are not associated with lymph node metastases.
Benech N; O'Brien JM; Barret M; Jacques J; Rahmi G; Perrod G; Hervieu V; Jaouen A; Charissoux A; Guillaud O; Legros R; Walter T; Saurin JC; Rivory J; Prat F; Lépilliez V; Ponchon T; Pioche M
United European Gastroenterol J; 2021 Apr; 9(3):362-369. PubMed ID: 32903167
[TBL] [Abstract][Full Text] [Related]
18. Risk of lymph node metastases in patients with T1b oesophageal adenocarcinoma: A retrospective single centre experience.
Graham D; Sever N; Magee C; Waddingham W; Banks M; Sweis R; Al-Yousuf H; Mitchison M; Alzoubaidi D; Rodriguez-Justo M; Lovat L; Novelli M; Jansen M; Haidry R
World J Gastroenterol; 2018 Nov; 24(41):4698-4707. PubMed ID: 30416317
[TBL] [Abstract][Full Text] [Related]
19. Predicting lymph node metastases in early esophageal adenocarcinoma using a simple scoring system.
Lee L; Ronellenfitsch U; Hofstetter WL; Darling G; Gaiser T; Lippert C; Gilbert S; Seely AJ; Mulder DS; Ferri LE
J Am Coll Surg; 2013 Aug; 217(2):191-9. PubMed ID: 23659947
[TBL] [Abstract][Full Text] [Related]
20. Role of lymphovascular invasion and immunohistochemical expression of IMP3 in the risk stratification of superficially invasive pT1 esophageal adenocarcinoma.
Trivedi A; Cartun RW; Ligato S
Pathol Res Pract; 2014 Jul; 210(7):402-6. PubMed ID: 24726263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
